Nektar Therapeutics (NKTR) Misses Q4 EPS by 24c
Tweet Send to a Friend
Nektar Therapeutics (NASDAQ: NKTR) reported Q4 EPS of ($0.41), $0.24 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
